Artia Global Partners’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-279,700
Closed -$45.7M 53
2026
Q1
$45.7M Sell
279,700
-140,300
-33% -$21.6M 9.16% 3
2025
Q4
$73.1M Buy
+420,000
New +$76.6M 10.36% 3
2024
Q3
Sell
-110,000
Closed -$7.37M 47
2024
Q2
$7.37M Buy
+110,000
New +$4.27M 1.42% 12

Other funds holding INSM

Artia Global Partners's INSM Position: Q2 2026 in Review

Artia Global Partners reduced its Insmed (INSM) stake by 6.3% in Q2 2026, selling an estimated $4.8M and leaving 589,052 shares worth $62.8M. The position accounts for 11.59% of the portfolio, ranked #2.

Artia Global Partners first reported a position in INSM in Q4 2023 and has held it in 11 quarters since. The position peaked at $119M in Q4 2025. 666 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Artia Global Partners held 589,052 shares of Insmed worth $62.8M as of Q2 2026.
  • Artia Global Partners sold 39,660 Insmed shares in Q2 2026, an estimated $4.8M.
  • Insmed made up 11.59% of Artia Global Partners's portfolio in Q2 2026, its #2 holding.
  • Artia Global Partners first reported a position in Insmed in Q4 2023 and has held it in 11 quarters since.
  • Artia Global Partners's Insmed position peaked at $119M in Q4 2025.
  • 666 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Artia Global Partners's 13F filing for Q2 2026, filed 14 Aug 2026.